The independent source for health policy research, polling, and news.
721 - 740 of 3,751 Results
A Florida woman tried to dispute an emergency room bill, but the hospital and collection agency refused to talk to her ā because it was her childās name on the bill, not hers.
The White House gathered the people who helped pass the Affordable Care Act 13 years ago ā partly to congratulate themselves but also to emphasize that they still have much work to do to make health care affordable.
The ranks of community-based behavioral health providers in Montana have diminished amid rising costs, greater need, and stagnant Medicaid reimbursement rates. Now, as state lawmakers debate solutions, providers are hoping just to cover their costs.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Hereās a collection of their appearances.
The state wants to stop paying Kaiser Permanente for treating severely mentally ill Medi-Cal patients in Sacramento and Solano counties and force the counties to take on the task. The countiesā leaders say they canāt afford it.
The federal government wants to change the way health insurers use prior authorization ā the requirement that patients get permission before undergoing treatment. Designed to prevent doctors from deploying expensive, ineffectual procedures, prior authorization has become a confusing maze that denies or delays care, burdens physicians with paperwork, and perpetuates racial disparities. New rules may not be enough to solve the problems.
Big Pharma may be moving on from squeezing diabetes patients on insulin prices, but itās the arbitrators that jack up prices for those who can least afford them.
States are turning to the big health insurance companies to keep Medicaid enrollees insured once pandemic protections end in April. The insurersā motive: profits.
President Joe Biden and Republicans in Congress spent last month sparring over whether to shield Medicare and Social Security from budget cuts ā leading some to wonder if Medicaid was on the table instead. Biden and Democrats say no, but some Republicans seem eager to trim federal spending on the health program for Americans with low incomes. And ready or not, artificial intelligence is coming to medical care. Benefits, as well as unintended consequences, are likely. Alice Miranda Ollstein of Politico, Rachel Cohrs of STAT News, and Lauren Weber of The Washington Post join KHNās chief Washington correspondent, Julie Rovner, to discuss these issues and more.
States take drastically different approaches to recovering Medicaid money from deceased participantsā estates. Demands for repayment of Medicaid spending can drain the assets a person leaves behind, depending on where they lived.
Medi-Cal serves more than one-third of the stateās population ā offering a dizzying range of care to a diverse population. In the new āFaces of Medi-Calā series, California Healthline will assess the programās strengths and weaknesses through the lives and experiences of its enrollees.
The removals, detailed in emails between state and federal health officials, hinged on disagreements over how states could disenroll people during the public health emergency. Consumer advocates fear the alleged violation signals the mess to come on April 1, when the pandemic-era Medicaid coverage mandate ends.
As many lower-income Americans prepare to lose pandemic-era access to Medicaid, President Joe Biden vowed to stop Republicans from making deeper cuts to lower the national debt. Other changes may still be up for discussion.
Billing experts and lawmakers are playing catch-up as providers find ways to get around new surprise-billing laws, leaving patients like Danielle Laskey of Washington state with big bills for emergency care.
KHN gives readers a chance to comment on a recent batch of stories.
Nearly half a million Californians without legal residency make too much to qualify for Medicaid yet they canāt afford to buy coverage. A state lawmaker is proposing to open up the stateās health insurance exchange as a first step to providing them affordable insurance.
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
CMS advanced two proposed changes that could affect Medicare Advantage plans. One would allow the government to recover past overpayments. As a result, it could reduce those insurersā profits, leading them to increase enrollees' out-of-pocket costs or reduce benefits. But it's inaccurate to characterize the changes as "cuts."
The first installment of InvestigateTV and KHNās āCostly Careā series explores one California motherās experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
Ā© 2026 KFF